Randomised clinical trial: safety, pharmacokinetics and pharmacodynamics of trazpiroben (TAK-906), a dopamine D2 /D3 receptor antagonist, in patients with gastroparesis - Kuo, B; Scimia, C; Dukes, G (Aliment Pharmacol Ther, 2021)
et al.